EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Melatonin Treatment in Kidney Diseases

Magdalena Markowska iD, Stanisław Niemczyk, Katarzyna Romejko iD

Cells · 08.03.2023 · 12 (6) · 838

DOI: 10.3390/cells12060838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 08.03.2023. Verfasst von Magdalena Markowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaserów Street, 04-141 Warsaw, Poland. Hauptthemen laut MEDLINE: Melatonin, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninRenal Insufficiency, ChronicHumansQuality of LifeAntioxidantsKidney

Stichwörter der Autor:innen

acute kidney injurychronic kidney diseasekidney diseasesmelatoninnephrotoxicityrenoprotective effect

Substanzen

MelatoninAntioxidants

Autor:innen und Institutionen

  • Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaserów Street, 04-141 Warsaw, Poland.

ORCID-Profile: Magdalena Markowska, Katarzyna Romejko

Zitieren

APA

Markowska, M., Niemczyk, S., & Romejko, K. (2023). Melatonin Treatment in Kidney Diseases. Cells, 12(6), 838. https://doi.org/10.3390/cells12060838

Vancouver

Markowska M, Niemczyk S, Romejko K. Melatonin Treatment in Kidney Diseases. Cells. 2023;12(6):838. doi:10.3390/cells12060838

BibTeX
@article{Markowska2023,
  author = {Markowska, Magdalena and Niemczyk, Stanisław and Romejko, Katarzyna},
  title = {Melatonin Treatment in Kidney Diseases},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {838},
  doi = {10.3390/cells12060838}
}
Kostenlos starten →